Target intelligence / Profile preview

Collagen type IV alpha-3-4-5 network (Collagen IV α345)

Target
Collagen IV α345
Molecular classification
Structural protein, Extracellular matrix protein, Other
01

Overview

The Collagen type IV alpha-3-4-5 network is a specialized extracellular matrix scaffold that forms the structural backbone of the mature glomerular basement membrane (GBM) in the kidney, as well as basement membranes in the cochlea and eye. Composed of heterotrimers of the alpha-3, alpha-4, and alpha-5 chains of type IV collagen (encoded by the COL4A3, COL4A4, and COL4A5 genes), this network replaces the developmental alpha-1-1-2 network during glomerular maturation to provide superior mechanical stability and permselectivity. Mutations in any of these three genes disrupt the assembly of the network, leading to Alport syndrome, a progressive hereditary nephritis characterized by GBM lamellation, hematuria, proteinuria, and eventual end-stage renal disease, often accompanied by sensorineural hearing loss and ocular defects. Additionally, the non-collagenous (NC1) domain of the alpha-3 chain serves as the primary autoantigen in Goodpasture syndrome (anti-GBM disease), where pathogenic autoantibodies trigger rapidly progressive glomerulonephritis and pulmonary hemorrhage. Therapeutic strategies targeting this network include standard-of-care RAAS inhibitors (such as ramipril and losartan) and SGLT2 inhibitors (such as dapagliflozin) to reduce mechanical strain, immunosuppressive regimens (such as cyclophosphamide and rituximab) to suppress autoantibody production in Goodpasture syndrome, and emerging nonsense mutation read-through therapies (such as exaluren/ELX-02) designed to restore full-length collagen IV expression.

Other names
Collagen IV alpha-3-4-5 networkCollagen IV alpha-3/4/5 networkCollagen type IV alpha-3-4-5 networkCollagen type IV alpha-3/4/5 networkα3α4α5(IV) collagenCollagen IV alpha 3-4-5 heterotrimerGoodpasture antigenGBM collagen IV networkCOL4A3/4/5 networkCollagen IV alpha-3-4-5 scaffold
02

Mechanism of action

Restoration of the structural network through nonsense mutation read-through therapy (e.g., exaluren/ELX-02); stabilization of mutant collagen folding via chemical chaperones; reduction of intraglomerular pressure and proteinuria via RAAS and SGLT2 inhibition; and removal or suppression of autoantibodies in autoimmune disease.

03

Biological functions

Structural supportGlomerular filtrationCell adhesionSignal transductionOther
04

Disease associations

InflammationOther
05

Safety considerations

Renal failure progressionImmunosuppression-related infections (for autoimmune treatments)Hyperkalemia and acute kidney injury (for RAAS inhibitors)Dehydration and genitourinary infections (for SGLT2 inhibitors)Ototoxicity and ocular complications associated with Alport syndrome progression
06

Interacting drugs

12 more in the full profile.

07

Biomarkers

ProteinuriaHematuriaUrine protein-to-creatinine ratio (UPCR)Glomerular filtration rate (GFR)Anti-glomerular basement membrane (anti-GBM) antibodiesCollagen IV alpha-5 expression in skin or kidney biopsy

Beyond the preview

Go deeper on Collagen type IV alpha-3-4-5 network (Collagen IV α345).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Collagen type IV alpha-3-4-5 network (Collagen IV α345).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call